Evidence map›Paper›PMID 31316458›Full record

ArticleFrontiers in neurology2019

HTRA1 Mutations Identified in Symptomatic Carriers Have the Property of Interfering the Trimer-Dependent Activation Cascade.

Masahiro Uemura, Hiroaki Nozaki, Akihide Koyama, Naoko Sakai, Shoichiro Ando, Masato Kanazawa, Taisuke Kato, Osamu Onodera

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Inappropriate interpretation of non-pathogenic HTRA1 variant as pathogenic.Annals of clinical and translational neurology · 2023
    Article
  10. Article
  11. Heterozygous Pathogenic and Likely Pathogenic SymptomaticInternational journal of general medicine · 2023
    Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Identified novel heterozygousFrontiers in genetics · 2022
    Article
  18. Article
  19. Frontiers in neurology · 2020
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Masahiro UemuraDepartment of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.
Hiroaki NozakiDepartment of Medical Technology, Graduate School of Health Sciences, Niigata University, Niigata, Japan.
Akihide KoyamaDepartment of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.
Naoko SakaiDepartment of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.
Shoichiro AndoDepartment of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.
Masato KanazawaDepartment of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.
Taisuke KatoDepartment of System Pathology for Neurological Disorders, Brain Research Institute, Niigata University, Niigata, Japan.
Osamu OnoderaDepartment of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.
Niigata University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CARASILcarriersheritabilityHTRA1mutationsvascular dementia

Identifiers

PMID31316458
PMCPMC6611441
OpenAlexW2949693295

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.